Skip to main content
SpringerLink
Log in

Vasculitides

A. Giant Cell Arteritis, Polymyalgia Rheumatica, and Takayasu’s Arteritis

  • Chapter
Primer on the Rheumatic Diseases

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Hunder GG. Giant cell arteritis and polymyalgia rheumatica. Med Clin North Am 1997;811:195–219.

    Article  Google Scholar 

  2. Weyand CM, Goronzy JJ. Medium-and large-vessel vasculitis. N Engl J Med 2003;349:160–169.

    Article  PubMed  CAS  Google Scholar 

  3. Ma-Krupa W, Jeon MS, Spoerl S, et al. Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis. J Exp Med 2004;1992:173–183.

    Article  CAS  Google Scholar 

  4. Weyand CM, Wagner AD, Bjornsson J, et al. Correlation of the topographical arrangement and the functional pattern of tissue-infiltrating macrophages in giant cell arteritis. J Clin Invest 1996;987:1642–1649.

    Google Scholar 

  5. Rittner HL, Kaiser M, Brack A, et al. Tissue-destructive macrophages in giant cell arteritis. Circ Res 1999;849:1050–1058.

    Google Scholar 

  6. Weyand CM, Tetzlaff N, Bjornsson J, et al. Disease patterns and tissue cytokine profiles in giant cell arteritis. Arthritis Rheum 1997;401:19–26.

    Article  Google Scholar 

  7. Weyand CM, Goronzy JJ. Arterial wall injury in giant cell arteritis. Arthritis Rheum 1999;425:844–853.

    Article  Google Scholar 

  8. Kaiser M, Weyand CM, Bjornsson J, et al. Platelet-derived growth factor, intimal hyperplasia, and ischemic complications in giant cell arteritis. Arthritis Rheum 1998;414:623–633.

    Article  Google Scholar 

  9. Kaiser M, Younge B, Bjornsson J, et al. Formation of new vasa vasorum in vasculitis. Production of angiogenic cytokines by multinucleated giant cells. Am J Pathol 1999;1553:765–774.

    Google Scholar 

  10. Rittner HL, Hafner V, Klimiuk PA, et al. Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis. J Clin Invest 1999;1037:1007–1013.

    Google Scholar 

  11. Weyand CM, Goronzy JJ. Giant-cell arteritis and polymyalgia rheumatica. Ann Intern Med 2003;1396:505–515.

    Google Scholar 

  12. Brack A, Martinez-Taboada V, Stanson A, et al. Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum 1999;422:311–317.

    Article  Google Scholar 

  13. Nuenninghoff DM, Hunder GG, Christianson TJ, et al. Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a populationbased study over 50 years. Arthritis Rheum 2003;4812:3522–3531.

    Article  Google Scholar 

  14. Evans JM, O’Fallon WM, Hunder GG. Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population-based study. Ann Intern Med 1995;1227:502–507.

    Google Scholar 

  15. Smetana GW, Shmerling RH. Does this patient have temporal arteritis? JAMA 2002;2871:92–101.

    Article  Google Scholar 

  16. Weyand CM, Fulbright JW, Hunder GG, et al. Treatment of giant cell arteritis: interleukin-6 as a biologic marker of disease activity. Arthritis Rheum 2000;435:1041–1048.

    Article  Google Scholar 

  17. Seo P, Stone JH. Large-vessel vasculitis. Arthritis Rheum 2004;511:128–139.

    Article  Google Scholar 

  18. Salvarani C, Silingardi M, Ghirarduzzi A, et al. Is duplex ultrasonography useful for the diagnosis of giant-cell arteritis? Ann Intern Med 2002;1374:232–238.

    Google Scholar 

  19. Hayreh SS, Zimmerman B, Kardon RH. Visual improvement with corticosteroid therapy in giant cell arteritis. Report of a large study and review of literature. Acta Ophthalmol Scand 2002;804:355–367.

    Article  Google Scholar 

  20. Hoffman GS, Cinta-Cid M, Hellmann D, et al. A multicenter placebo-controlled study of methotrexate (MTX) in giant cell ateritis (GCA). Arthritis Rheum 2000;43: S115.

    Article  Google Scholar 

  21. Hoffman GS, Cinta-Cid M, Rendt KE, et al. Prednisone and infliximab for giant cell arteritis: a randomized, double-blind, placebo-controlled, multicenter study of efficacy and safety. Ann Int Med 2007;146:621–630.

    PubMed  Google Scholar 

  22. Mazlumzadeh M, Hunder GG, Easley KA, et al. Treatment of giant cell arteritis: induction therapy with high dose glucocorticoids. Arthritis Rheum 2006;54:3310–3318.

    Article  PubMed  CAS  Google Scholar 

  23. Nesher G, Berkun Y, Mates M, et al. Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis. Arthritis Rheum 2004;50:1332–1337.

    Article  PubMed  CAS  Google Scholar 

  24. Salvarani C, Cantini F, Boiardi L, et al. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med 2002;3474:261–271.

    Article  Google Scholar 

  25. Weyand CM, Hicok KC, Hunder GG, et al. Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis. Ann Intern Med 1994;1217:484–491.

    Google Scholar 

  26. Weyand CM, Fulbright JW, Evans JM, et al. Corticosteroid requirements in polymyalgia rheumatica. Arch Intern Med 1999;1596:577–584.

    Article  Google Scholar 

  27. Salvarani C, Cantini F, Olivieri I, et al. Proximal bursitis in active polymyalgia rheumatica. Ann Intern Med 1997;1271:27–31.

    Google Scholar 

  28. Kerr GS. Takayasu’s arteritis. Rheum Dis Clin North Am 1995;214:1041–1058.

    Google Scholar 

  29. Numano F. Differences in clinical presentation and outcome in different countries for Takayasu’s arteritis. Curr Opin Rheumatol 1997;91:12–15.

    Article  Google Scholar 

  30. Seko Y. Takayasu arteritis: insights into immunopathology. Jpn Heart J 2000;411:15–26.

    Article  Google Scholar 

  31. Kimura A, Kitamura H, Date Y, et al. Comprehensive analysis of HLA genes in Takayasu arteritis in Japan. Int J Cardiol 1996;54(Suppl):S61–S69.

    Article  PubMed  Google Scholar 

  32. Kissin EY, Merkel PA. Diagnostic imaging in Takayasu arteritis. Curr Opin Rheumatol 2004;161:31–37.

    Article  Google Scholar 

  33. Liang P, Hoffman GS. Advances in the medical and surgical treatment of Takayasu arteritis. Curr Opin Rheumatol 2005;171:16–24.

    Article  Google Scholar 

  34. Kerr GS, Hallahan CW, Giordano J, et al. Takayasu arteritis. Ann Intern Med 1994;12011:919–929.

    Google Scholar 

  35. Langford CA, Sneller MC, Hoffman GS. Methotrexate use in systemic vasculitis. Rheum Dis Clin North Am 1997;234:841–853.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Kathleen B. and Mason I. Lowance Center for Human Immunology, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA

    Cornelia M. Weyand MD (Co-Director) & JÖrg J. Goronzy MD (Co-Director)

Authors
  1. Cornelia M. Weyand MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. JÖrg J. Goronzy MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Arthritis Foundation, Atlanta, GA, USA

    John H. Klippel MD (President and CEO) & Patience H. White MD, MA (Chief Public Health Officer) (President and CEO) &  (Chief Public Health Officer)

  2. Massachusetts General Hospital, Deputy Editor for Rheumatology UpToDate, Boston, MA, USA

    John H. Stone MD, MPH (Associate Physician) (Associate Physician)

  3. Division of Rheumatology & Women’s Health, University of Kentucky, Lexington, KY, USA

    Leslie J. Crofford MD (Gloria W. Singletary Professor of Internal Medicine, Chief) (Gloria W. Singletary Professor of Internal Medicine, Chief)

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer Science+Business Media, LLC.

About this chapter

Cite this chapter

Weyand, C.M., Goronzy, J.J. (2008). Vasculitides. In: Klippel, J.H., Stone, J.H., Crofford, L.J., White, P.H. (eds) Primer on the Rheumatic Diseases. Springer, New York, NY. https://doi.org/10.1007/978-0-387-68566-3_51

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-68566-3_51

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-35664-8

  • Online ISBN: 978-0-387-68566-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation